Serenity Bioworks (Seed)

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Spencer Berg, Cody Shirriff
Company Description
Serenity BioWorks is developing an immune-compatible gene therapy platform. We have identified key receptors on macrophages that potently modulate macrophage activity. We have successfully demonstrated that targeting these receptors avoids pro-inflammatory responses initiated by innate receptors or the inflammasome.
Market
Human Health
Location
Canada

Links
Back to Home Back to Biopharma Deals View Funding Announcement